Showing results (61-70 of 135) with videos related to
Sort By:
Pageof 14
The Journal of Mental Health Policy and Economics|January 17, 2003
An analysis of the diffusion of new antidepressants: variety, quality, and marketing effortsErnst R Berndt, Ashoke Bhattacharjya, David N Mishol, et al.Pharmacogenomics|February 12, 2013
Uncertain prognosis for high-quality diagnostics: clinical challenges, economic barriers and needed reformsMark R Trusheim, M J Finley Austin, Carsten Rausch, et al.JAMA Internal Medicine|May 31, 2017
Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal SpendingStacie B Dusetzina, Rena M Conti, Nancy L Yu, et al.Pediatrics|August 17, 2021
Opioid Prescribing to US Children and Young Adults in 2019Kao-Ping Chua, Chad M Brummett, Rena M Conti, et al.American Journal of Preventive Medicine|June 23, 2022
Dispensing of HIV and Hepatitis C Antivirals During COVID-19: An Interrupted Time-Series Analysis of U.S. National DataTimothy W Levengood, Andrew I Aronsohn, Kao-Ping Chua, et al.JAMA Health Forum|August 17, 2022
Prevalence and Magnitude of Potential Surprise Bills for ChildbirthKao-Ping Chua, A Mark Fendrick, Rena M Conti, et al.Pediatrics|February 26, 2024
Antidepressant Dispensing to US Adolescents and Young Adults: 2016-2022Kao-Ping Chua, Anna Volerman, Jason Zhang, et al.Bulletin of the World Health Organization|January 25, 2012
Advance market commitment for pneumococcal vaccines: putting theory into practiceTania Cernuschi, Eliane Furrer, Nina Schwalbe, et al.Nature Reviews. Drug Discovery|July 30, 2005
Industry funding of the FDA: effects of PDUFA on approval times and withdrawal ratesErnst R Berndt, Adrian H B Gottschalk, Tomas J Philipson, et al.Pediatrics|May 2, 2025
Changes in Chronic Medication Dispensing to Children and Young Adults During Medicaid UnwindingKao-Ping Chua, Joanne Constantin, Genevieve M Kenney, et al.Pageof 14